TipRanks
Go Ultimate55% OFF

Cipher Pharmaceuticals (CPH) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Spinosad TopicalScabiesPhase IVRecruitingPK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With ScabiesMar 09, 2022―
Moxifloxacin 400 Mg, Tramadol HclHealthyPhase ICompletedStudy to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy ParticipantsDec 02, 2014―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Cipher Pharmaceuticals Inc (TSE:CPH) have in its pipeline
Cipher Pharmaceuticals TSE:CPH is currently developing the following drugs: Spinosad Topical, Moxifloxacin 400 Mg, Tramadol Hcl. These drug candidates are in various stages of clinical development as the company works toward FDA approval.